The PDF was saved in your download folder or opened in a new tab in your browser. You can find the download folder on your drive or in the browser bar of Firefox and Safari at the top right next to the arrow icon.
The Board of Directors
Since the beginning of 2021, the MLL Munich Leukemia Laboratory is headed by the four-member Board of Directors, consisting of the management, Prof. Dr. med. Claudia Haferlach, Prof. Dr. med. Dr. phil. Torsten Haferlach, Prof. Dr. med. Wolfgang Kern, and Dr. rer. nat. Manja Meggendorfer, Head of Molecular Genetics and Research and Development. The Board of Directors is responsible, among other things, for the management of the company and for the coordination of all internal and external company processes.
The department management
Each department and division of MLL is functionally assigned to a department manager in order to ensure straightforward communication and control of the laboratory. The tasks of the department manager include the strategic organization of the company, the definition of goals and the continuous development of the company.
from left to right: Jonas Reiter, Prof. Dr. Claudia Haferlach, Dr. Christian Pohlkamp, Prof. Dr. Dr. Torsten Haferlach, Prof. Dr. Wolfgang Kern, Dr. Manja Meggendorfer
Prof. Dr. Claudia Haferlach was Head of the Cytogenetics and Fluorescence In-situ Hybridization Department at the Laboratory for Special Leukemia Diagnostics, Clinic Munich-Großhadern, is cofounder of MLL and since 2005 has been Head of the Cytogenetics and Fluorescence In-situ Hybridization Department at MLL.
Before cofounding MLL in 2005, Prof. Dr. Dr. Haferlach was a senior physician at various large university clinics with habilitation in internal medicine and a specialization in hematology and internal oncology
Prof. Dr. Kern was in charge of immunophenotyping at the Laboratory for Special Leukemia Diagnostics, Clinic Munich-Großhadern, is cofounder of MLL and since 2005 has been Head of the Immunophenotyping Department at MLL.
At the heart of our work is the responsibility we accept for people suffering from leukemia in its various forms. Modern leukemia diagnosis demands a large and closely connected team of experienced physicians, biologists, bioinformatics specialists and medical technicians. Consistent sharing of test results between the various laboratory departments and the steady expansion of staff knowledge guarantee rapid and reliable diagnostics in each individual case. The team of excellently qualified staff members is therefore the nerve center at MLL.